Erratum: Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561368/
https://www.ncbi.nlm.nih.gov/pubmed/28798079
http://dx.doi.org/10.1136/annrheumdis-2016-210094corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561368/
https://www.ncbi.nlm.nih.gov/pubmed/28798079
http://dx.doi.org/10.1136/annrheumdis-2016-210094corr1

Ejemplares similares